Last reviewed · How we verify

[18F]-PI-2620

University of Pennsylvania · Phase 3 active Small molecule

PET imaging agent for amyloid plaques

PET imaging agent for amyloid plaques Used for Amyloid imaging for Alzheimer's disease.

At a glance

Generic name[18F]-PI-2620
SponsorUniversity of Pennsylvania
TargetAmyloid plaques
ModalitySmall molecule
Therapeutic areaNeurology
PhasePhase 3

Mechanism of action

18F-PI-2620 is a radiolabeled compound that selectively binds to amyloid plaques, allowing for the visualization of amyloid burden in the brain.

Approved indications

Common side effects

No common side effects on file.